RLRenaud Lopes

Renaud Lopes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Renaud Lopes has a total of 385 co-authors. Here are the top co-authors by number of shared publications:

  • Xavier Leclerc

    U1172 – LilNCog (Lille Neuroscience & Cognition) Univ. Lille, Inserm, CHU Lille Lille France

    11 shared publications
  • Grégory Kuchcinski

    Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France; CHU Lille, Département de Neuroradiologie, F-59000 Lille, France

    9 shared publications
  • Alberto Beltramello

    Department of Neuroradiology General Hospital Verona Italy

    8 shared publications
  • Christine Delmaire

    Hopital Fondation Adolphe de Rothschild, Paris, France

    8 shared publications
  • David Bartrés-Faz

    Department of Medicine, Faculty of Medicine and Health Sciences, Institute of Neurosciences, University of Barcelona, Barcelona, Spain

    8 shared publications
  • Flavio Nobili

    IRCCS Ospedale Policlinico San Martino, Genoa, Italy

    8 shared publications

Latest Publications

  • Open Access

    NeuroHarm‑Kit: An open‑source toolbox for benchmarking deep‑learning harmonization of multi‑site T1‑weighted MRI

    by Barnabé Hache, Vincent Roca, Grégory Kuchcinski, Dorian Manouvriez, Renaud Lopes

  • Analyses fractale et multifractale en imagerie médicale : outils, validations et applications

    by Renaud Lopes

    La géométrie fractale, comprenant les analyses fractales et multifractales, est un outil en émergence dans de nombreux domaines d’applications et notamment en imagerie médicale. Elle consiste à formuler une mesure de l’hétérogénéité globale ou locale d’un signal (1D, 2D ou 3D). En imagerie médicale, son utilisation est souvent limitée au cas 1D ou 2D et ses domaines d’applications restent essentiellement restreints à la discrimination entre deux états (sains/pathologiques) grâce à une analyse globale du signal. L’objectif de cette thèse est de fournir à la fois des outils 3D de mesures des hétérogénéités globale (volume) et locale (voxel) basées sur la géométrie fractale. Les deux indices utilisés sont la dimension fractale et le spectre multifractal (coefficients de Hölder). Etant donné que les algorithmes de ces outils ne peuvent formuler que des estimations de la valeur théorique, nous utilisons des volumes de synthèses fractals et multifractals pour les valider. Les différents développements offrent ainsi non seulement des outils de discrimination mais également des outils de segmentation de texture. Ce deuxième point est particulièrement intéressant, car le développement de nouveaux attributs de texture est un domaine de recherche actif du fait de l’évolution incessante des technologies d’imagerie. Afin de valider et de montrer l’intérêt de la géométrie fractale, deux applications sont étudiées : la caractérisation des foyers épileptogènes sur des images de tomographie par émission mono-photonique, et la détection des tumeurs prostatiques sur des images IRM pondérées T2. L’efficacité des attributs fractals et multifractals sont étudiés à travers un schéma de classification supervisée. Les résultats concluants pour les deux applications démontrent l’intérêt de cette géométrie et son adaptabilité à différentes applications en imagerie médicale.

  • Open Access

    The MULTIMODHAL randomized controlled trial: fMRI-based symptom capture for guiding rTMS treatment of drug-resistant hallucinations in patients with schizophrenia

    by Renaud Jardri, Pierre Yger, Zaineb Amor, Marion Plaze, Ali Amad, David Roman, Sébastien Szaffarczyk, Stéphanie Lefebvre, Delphine Pins, Macarena Cuenca, et al.

    Auditory–verbal hallucinations (AVHs) are among the most disabling symptoms of schizophrenia and often persist despite the use of adequate antipsychotic treatment. Conventional low-frequency repetitive transcranial magnetic stimulation (rTMS) targeting the T3P3 scalp site has demonstrated limited efficacy, likely due to interindividual variability in AVH-related brain networks. In this multicenter, randomized, double-blind phase 3 trial, 70 patients with drug-resistant AVHs received active 1-Hz rTMS targeted either with an individualized fMRI-based symptom-capture procedure or by using conventional T3P3 localization. fMRI-guided rTMS yielded a greater reduction in Auditory Hallucination Rating Scale (AHRS) scores at one month (mean difference, −5.43; 95% CI, −8.92 to −1.94), and the effects were sustained at three and six months. The number-needed-to-treat for neuroguided rTMS was 3.5. Clinical response was associated with greater E-field overlap with AVH-related networks. These findings demonstrate that fMRI-guided neuronavigation increases rTMS efficacy, thus supporting its use to optimize the treatment of drug-resistant AVHs in schizophrenia.

  • Open Access

    Long‐Term Post‐Stroke Cognition in Patients With Minor Ischemic Stroke is Related to Tract‐Based Disconnection Induced by White Matter Hyperintensities

    by Renaud Lopes, Grégory Kuchcinski, Thibaut Dondaine, Loïc Duron, Anne‐Marie Mendyk, Hilde Hénon, Charlotte Cordonnier, Jean‐Pierre Pruvo, Régis Bordet, Xavier Leclerc

    Over a third of minor stroke patients experience post‐stroke cognitive impairment (PSCI), but no validated tools exist to identify at‐risk patients early. This study investigated whether disconnection features derived from infarcts and white matter hyperintensities (WMH) could serve as markers for short‐ and long‐term cognitive decline in first‐ever minor ischemic stroke patients. First‐ever minor ischemic stroke patients (NIHSS ≤ 7) were prospectively followed at 72‐h, 6 months, and 36 months post‐stroke with cognitive tests and brain MRI. Infarct and WMH volumes were semi‐automatically assessed on DWI and FLAIR sequences. Bayesian tract‐based disconnection models estimated remote pathological effects of infarcts and WMH. Associations between disconnection features and cognitive outcomes were analyzed using canonical correlation analyses, adjusted for age, education, and multiple comparisons. Among 105 patients (31% female, mean age 63 ± 12 years), infarct volume averaged 10.28 ± 17.10 cm3 and predominantly involved the middle cerebral artery territory (83%). WMH burden was higher in frontal periventricular white matter. Infarct‐based features did not significantly relate to PCSI. However, a WMH‐derived disconnection factor, involving commissural and frontal tracts, and the right superior longitudinal fasciculus, was significantly associated with PSCI at 6 months (OR = 9.96, p value = 0.02) and 36 months (OR = 12.27, p value = 0.006), particularly in executive/attention, language, and visuospatial domains. This factor, unrelated to WMH volume, outperformed demographic and clinical predictors of PSCI. WMH‐induced disconnection may be associated with short‐ and long‐term PSCI in minor stroke. Routine MR‐derived features could identify at‐risk patients for rehabilitation trials.


  • Multifractal Analysis in Neuroimaging

    by Renaud Lopes

    The characteristics of biomedical signals are not captured by conventional measures like the average amplitude of the signal. The methodologies derived from fractal geometry have been a very useful approach to study the degree of irregularity of a signal. The monofractal analysis of a signal is defined by a single power-law exponent in assuming a scale invariance in time and space. However, temporal and spatial variation in the scale-invariant structure of the biomedical signal often appears. In this case, multifractal analysis is well-suited because it is defined by a multifractal spectrum of power-law exponents. There are several approaches to the implementation of this analysis, and there are numerous ways to present these. In this chapter, we review the use of multifractal analysis for the purpose of characterizing signals in neuroimaging. After describing the tenets of multifractal analysis, we present several approaches to estimating the multifractal spectrum. Finally, we describe the applications of this spectrum on biomedical signals in the characterization of several diseases in neurosciences. Keywords Multifractal analysis Multifractal spectrum Electroencephalogram Brain imaging Neurological diseases


  • Open Access

    White Matter Hyperintensity Volume and Poststroke Cognition: An Individual Patient Data Pooled Analysis of 9 Ischemic Stroke Cohort Studies

    by Floor A.S. de Kort, Mirthe Coenen, Nick A. Weaver, Hugo J. Kuijf, Hugo P. Aben, Hee-Joon Bae, Régis Bordet, Guido Cammà, Christopher P.L.H. Chen, Anna Dewenter, et al.

    BACKGROUND: White matter hyperintensities (WMH) are associated with cognitive dysfunction after ischemic stroke. Yet, uncertainty remains about affected domains, the role of other preexisting brain injury, and infarct types in the relation between WMH burden and poststroke cognition. We aimed to disentangle these factors in a large sample of patients with ischemic stroke from different cohorts. METHODS: We pooled and harmonized individual patient data (n=1568) from 9 cohorts, through the Meta VCI Map consortium ( www.metavcimap.org ). Included cohorts comprised patients with available magnetic resonance imaging and multidomain cognitive assessment Z scores; attention and executive functioning, processing speed, language and verbal memory) for the total sample and stratified by infarct type. Preexisting brain injury was accounted for in the multivariable models and all analyses were corrected for the study site as a random effect. RESULTS: In the total sample (67 years [SD, 11.5], 40% female), we found a dose-dependent inverse relationship between WMH volume and poststroke cognitive functioning across all 4 cognitive domains (coefficients ranging from −0.09 [SE, 0.04, P =0.01] for verbal memory to −0.19 [SE, 0.03, P <0.001] for attention and executive functioning). This relation was independent of acute infarct volume and the presence of lacunes and old infarcts. In stratified analyses, the relation between WMH volume and domain-specific functioning was also largely independent of infarct type. CONCLUSIONS: In patients with ischemic stroke, increasing WMH volume is independently associated with worse cognitive functioning across all major domains, regardless of old ischemic lesions and infarct type.


  • Open Access

    A three-dimensional deep learning model for inter-site harmonization of structural MR images of the brain: Extensive validation with a multicenter dataset

    by Vincent Roca, Grégory Kuchcinski, Jean-Pierre Pruvo, Dorian Manouvriez, Xavier Leclerc, Renaud Lopes


  • Open Access

    Tract-based disconnection induced by WMH in patients with minor stroke is related to long-term post-stroke cognition

    by Renaud Lopes, Grégory Kuchcinski, Thibaut Dondaine, Loïc Duron, Anne-Marie Mendyk, Hilde Hénon, Charlotte Cordonnier, Jean-Pierre Pruvo, Régis Bordet, Xavier Leclerc

    Background Over a third of minor stroke patients will suffer from post-stroke cognitive impairment (PSCI) but there are no validated tools to clearly identify at-risk patients in the early phase. We aimed to investigate the short and long-term cognitive decline using disconnection features from infarct and white matter hyperintensities (WMH) in first-ever minor ischemic stroke patients. Methods First-ever minor ischemic stroke patients (NIHSS≤7) were prospectively followed-up at 72-hour, 6- and 36-month post-stroke with cognitive tests and conventional brain MRI. Infarct and WMH volumes were semi-automatically evaluated on DWI and FLAIR sequences respectively. Bayesian models using tract-based structural disconnection were used to estimate the remote pathological effects of cerebral infarct and/or WMH. The disconnection approach was compared to features extracted from cerebral infarct and WMH volumes and locations. All lesion-based features were compared between patients with and without cognitive impairment at 6- and 36-month post-stroke. The potential association between the features and cognitive domains alterations was assessed by canonical correlation analyses. All statistical analyses were corrected for age, education and multiple comparisons. Results 105 patients (female, 31%) with a mean (± SD) age of 63 ± 12 years were enrolled. Infarct volume was 10.28 ± 17.10 cm3 and involved the middle cerebral artery territory in 83% of patients. The burden of WMH was higher within frontal periventricular white matter. Infarct-based features showed no significant relationship with 6 and 36-month PSCI. However, a WMH disconnection factor involving the commissural and frontal tracts was associated with 6- and 36-month PSCI, particularly in executive/attention, language and visuospatial domains. Memory domain alterations were associated with higher WMH burden in right temporal regions. Conclusions WMH-induced disconnectivity may predict short and long-term PSCI in minor ischemic stroke. These neuroimaging features extracted from routine MR sequences could help identifying at-risk patients to test future rehabilitation interventions.

  • Radiomics-Derived Brain Age Predicts Functional Outcome After Acute Ischemic Stroke

    by Martin Bretzner, Anna K. Bonkhoff, Markus D. Schirmer, Sungmin Hong, Adrian Dalca, Kathleen Donahue, Anne-Katrin Giese, Mark R. Etherton, Pamela M. Rist, Marco Nardin, et al.

    Background and Objectives While chronological age is one of the most influential determinants of poststroke outcomes, little is known of the impact of neuroimaging-derived biological “brain age.” We hypothesized that radiomics analyses of T2-FLAIR images texture would provide brain age estimates and that advanced brain age of patients with stroke will be associated with cardiovascular risk factors and worse functional outcomes. Methods We extracted radiomics from T2-FLAIR images acquired during acute stroke clinical evaluation. Brain age was determined from brain parenchyma radiomics using an ElasticNet linear regression model. Subsequently, relative brain age (RBA), which expresses brain age in comparison with chronological age-matched peers, was estimated. Finally, we built a linear regression model of RBA using clinical cardiovascular characteristics as inputs and a logistic regression model of favorable functional outcomes taking RBA as input. Results We reviewed 4,163 patients from a large multisite ischemic stroke cohort (mean age = 62.8 years, 42.0% female patients). T2-FLAIR radiomics predicted chronological ages (mean absolute error = 6.9 years, r = 0.81). After adjustment for covariates, RBA was higher and therefore described older-appearing brains in patients with hypertension, diabetes mellitus, a history of smoking, and a history of a prior stroke. In multivariate analyses, age, RBA, NIHSS, and a history of prior stroke were all significantly associated with functional outcome (respective adjusted odds ratios: 0.58, 0.76, 0.48, 0.55; all p-values < 0.001). Moreover, the negative effect of RBA on outcome was especially pronounced in minor strokes. Discussion T2-FLAIR radiomics can be used to predict brain age and derive RBA. Older-appearing brains, characterized by a higher RBA, reflect cardiovascular risk factor accumulation and are linked to worse outcomes after stroke.


  • Open Access

    Longitudinal Analysis of Brain-Predicted Age in Amnestic and Non-amnestic Sporadic Early-Onset Alzheimer's Disease

    by Morgan Gautherot, Grégory Kuchcinski, Cécile Bordier, Adeline Rollin Sillaire, Xavier Delbeuck, Mélanie Leroy, Xavier Leclerc, Jean-Pierre Pruvo, Florence Pasquier, Renaud Lopes

    Objective:Predicted age difference (PAD) is a score computed by subtracting chronological age from “brain” age, which is estimated using neuroimaging data. The goal of this study was to evaluate the PAD as a marker of phenotypic heterogeneity and severity among early-onset Alzheimer's disease (EOAD) patients.Methods:We first used 3D T1-weighted (3D-T1) magnetic resonance images (MRI) of 3,227 healthy subjects aged between 18 and 85 years to train, optimize, and evaluate the brain age model. A total of 123 participants who met the criteria for early-onset (n= 74) and a non-amnestic form (n= 49)] were included at baseline and followed-up for a maximum period of 4 years. All the participants underwent a work-up at baseline and every year during the follow-up period, which included clinical examination, neuropsychological testing and genotyping, and structural MRI. In addition, cerebrospinal fluid biomarker assay was recorded at baseline. PAD score was calculated by applying brain age model to 3D-T1 images of the EOAD patients and healthy controls, who were matched based on age and sex. At baseline, between-group differences for neuropsychological and PAD scores were assessed using linear models. Regarding longitudinal analysis of neuropsychological and PAD scores, differences between amnestic and non-amnestic participants were analyzed using linear mixed-effects modeling.Results:PAD score was significantly higher for non-amnestic patients (2.35 ± 0.91) when compared to amnestic patients (2.09 ± 0.74) and controls (0.00 ± 1). Moreover, PAD score was linearly correlated with the Mini-Mental State Examination (MMSE) and the Clinical Dementia Rating Sum of Boxes (CDR-SB), for both amnestic and non-amnestic sporadic forms. Longitudinal analyses showed that the gradual development of the disease in patients was accompanied by a significant increase in PAD score over time, for both amnestic and non-amnestic patients.Conclusion:PAD score was able to separate amnestic and non-amnestic sporadic forms. Regardless of the clinical presentation, as PAD score was a way of quantifying an early brain age acceleration, it was an appropriate method to detect the development of AD and follow the evolution of the disease as a marker of severity as MMSE and CDR-SB.